Is Aura Biosciences, Inc. (AURA) a Buy, Sell, or Hold?
Aura Biosciences, Inc.
NASDAQ:AURA
$7.01 USD
$0.01 (0.14%)
- Volume
- 304.32K
- Average Volume
- 660.91K
- Market Capitalization
- $450.04M
- P/E Ratio
- -3.96
- Dividend Yield
- 0.00%
- Price Target
- $17.00
- Year High
- $9.54
- Year Low
- $4.73
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $7.09
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
26
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
14
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 7.11M
AURA Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
AURA Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Bender Jeremy | director | 2026-07-07 | A-Award | 7.03 | 2026-07-08 |
| Bender Jeremy | director | 2026-07-07 | A-Award | 0 | 2026-07-08 |
| Bender Jeremy | 2026-07-07 | 0 | 2026-07-08 | ||
| Kilroy Conor | officer: See Remarks | 2026-07-01 | A-Award | 0 | 2026-07-01 |
| Gibney Anthony S | officer: See Remarks | 2026-06-16 | S-Sale | 6.42 | 2026-06-16 |
| Bitetti Teresa Marie | director | 2026-06-11 | A-Award | 0 | 2026-06-15 |
| Bitetti Teresa Marie | director | 2026-06-11 | A-Award | 6.21 | 2026-06-15 |
| Srivastava Sapna | director | 2026-06-11 | A-Award | 0 | 2026-06-15 |
| Srivastava Sapna | director | 2026-06-11 | A-Award | 6.21 | 2026-06-15 |
| Johnson David Michael | director | 2026-06-11 | A-Award | 0 | 2026-06-15 |
| Johnson David Michael | director | 2026-06-11 | A-Award | 6.21 | 2026-06-15 |
| Mattessich Antony C. | director | 2026-06-11 | A-Award | 0 | 2026-06-15 |
| Mattessich Antony C. | director | 2026-06-11 | A-Award | 6.21 | 2026-06-15 |
| Holles Natalie C. | director, officer: See Remarks | 2026-05-19 | A-Award | 7.39 | 2026-05-19 |
| Holles Natalie C. | director, officer: See Remarks | 2026-05-19 | A-Award | 0 | 2026-05-19 |
| Holles Natalie C. | director, officer: See Remarks | 2026-05-19 | A-Award | 0 | 2026-05-19 |
| Matrix Capital Management Company, LP | 10 percent owner | 2026-05-07 | S-Sale | 5.64 | 2026-05-11 |
| Holles Natalie C. | 2026-04-30 | 0 | 2026-05-07 | ||
| Kilroy Conor | officer: See Remarks | 2026-04-16 | S-Sale | 7.02 | 2026-04-16 |
| Kilroy Conor | officer: See Remarks | 2026-03-02 | A-Award | 0 | 2026-03-03 |
| Kilroy Conor | officer: See Remarks | 2026-03-02 | A-Award | 6.14 | 2026-03-03 |
| Gibney Anthony S | officer: See Remarks | 2026-03-02 | A-Award | 0 | 2026-03-03 |
| Gibney Anthony S | officer: See Remarks | 2026-03-02 | A-Award | 6.14 | 2026-03-03 |
| de los Pinos Elisabet | director, officer: See Remarks | 2026-03-02 | A-Award | 0 | 2026-03-03 |
| de los Pinos Elisabet | director, officer: See Remarks | 2026-03-02 | A-Award | 6.14 | 2026-03-03 |
| Plavsic Mark | officer: Chief Technology Officer | 2026-03-02 | A-Award | 0 | 2026-03-03 |
| Plavsic Mark | officer: Chief Technology Officer | 2026-03-02 | A-Award | 6.14 | 2026-03-03 |
| Hopkins Janet Jill | officer: Chief Medical Officer | 2026-03-02 | A-Award | 0 | 2026-03-03 |
| Hopkins Janet Jill | officer: Chief Medical Officer | 2026-03-02 | A-Award | 6.14 | 2026-03-03 |
| Elazzouzi Amy | officer: Senior Vice President, Finance | 2026-03-02 | A-Award | 0 | 2026-03-03 |
| Elazzouzi Amy | officer: Senior Vice President, Finance | 2026-03-02 | A-Award | 6.14 | 2026-03-03 |
| Kilroy Conor | officer: See Remarks | 2026-02-17 | S-Sale | 5.05 | 2026-02-17 |
| Plavsic Mark | officer: Chief Technology Officer | 2026-02-17 | S-Sale | 5.05 | 2026-02-17 |
| Hopkins Janet Jill | officer: Chief Medical Officer | 2026-02-17 | S-Sale | 5.06 | 2026-02-17 |
| Elazzouzi Amy | officer: Senior Vice President, Finance | 2026-02-17 | S-Sale | 5.06 | 2026-02-17 |
| de los Pinos Elisabet | director, officer: See Remarks | 2026-02-17 | S-Sale | 5.06 | 2026-02-17 |
| Elazzouzi Amy | officer: Senior Vice President, Finance | 2026-01-20 | S-Sale | 4.86 | 2026-01-20 |
| de los Pinos Elisabet | director, officer: See Remarks | 2026-01-20 | S-Sale | 4.86 | 2026-01-20 |
| Hopkins Janet Jill | officer: Chief Medical Officer | 2025-11-17 | S-Sale | 5.42 | 2025-11-17 |
| Elazzouzi Amy | officer: Senior Vice President, Finance | 2025-10-29 | S-Sale | 6.35 | 2025-10-29 |
| de los Pinos Elisabet | director, officer: See Remarks | 2025-10-29 | S-Sale | 6.35 | 2025-10-29 |
| Plavsic Mark | officer: Chief Technology Officer | 2025-10-16 | S-Sale | 6.35 | 2025-10-16 |
| Elazzouzi Amy | officer: Senior Vice President, Finance | 2025-08-18 | M-Exempt | 4.25 | 2025-08-18 |
| Elazzouzi Amy | officer: Senior Vice President, Finance | 2025-08-18 | M-Exempt | 3.16 | 2025-08-18 |
| Elazzouzi Amy | officer: Senior Vice President, Finance | 2025-08-18 | M-Exempt | 2.74 | 2025-08-18 |
| Elazzouzi Amy | officer: Senior Vice President, Finance | 2025-08-18 | S-Sale | 6.7 | 2025-08-18 |
| Elazzouzi Amy | officer: Senior Vice President, Finance | 2025-08-18 | M-Exempt | 5.21 | 2025-08-18 |
| Elazzouzi Amy | officer: Senior Vice President, Finance | 2025-08-18 | M-Exempt | 5.48 | 2025-08-18 |
| Elazzouzi Amy | officer: Senior Vice President, Finance | 2025-08-18 | M-Exempt | 5.48 | 2025-08-18 |
| Elazzouzi Amy | officer: Senior Vice President, Finance | 2025-08-18 | M-Exempt | 5.07 | 2025-08-18 |
| Elazzouzi Amy | officer: Senior Vice President, Finance | 2025-08-18 | M-Exempt | 5.07 | 2025-08-18 |
| Elazzouzi Amy | officer: Senior Vice President, Finance | 2025-08-18 | M-Exempt | 4.25 | 2025-08-18 |
| Elazzouzi Amy | officer: Senior Vice President, Finance | 2025-08-18 | M-Exempt | 5.48 | 2025-08-18 |
| Elazzouzi Amy | officer: Senior Vice President, Finance | 2025-08-18 | M-Exempt | 3.16 | 2025-08-18 |
| Elazzouzi Amy | officer: Senior Vice President, Finance | 2025-08-18 | M-Exempt | 5.21 | 2025-08-18 |
| Elazzouzi Amy | officer: Senior Vice President, Finance | 2025-08-18 | M-Exempt | 2.74 | 2025-08-18 |
| Srivastava Sapna | director | 2025-06-17 | A-Award | 0 | 2025-06-18 |
| Srivastava Sapna | director | 2025-06-17 | A-Award | 6.18 | 2025-06-18 |
| Johnson David Michael | director | 2025-06-17 | A-Award | 0 | 2025-06-18 |
| Johnson David Michael | director | 2025-06-17 | A-Award | 6.18 | 2025-06-18 |
| Mattessich Antony C. | director | 2025-06-17 | A-Award | 0 | 2025-06-18 |
| Mattessich Antony C. | director | 2025-06-17 | A-Award | 6.18 | 2025-06-18 |
| Gibney Anthony S | officer: See Remarks | 2025-06-02 | A-Award | 6.16 | 2025-06-04 |
| Gibney Anthony S | officer: See Remarks | 2025-06-02 | A-Award | 0 | 2025-06-04 |
| de los Pinos Elisabet | director, officer: See Remarks | 2025-06-02 | M-Exempt | 5.07 | 2025-06-04 |
| de los Pinos Elisabet | director, officer: See Remarks | 2025-06-02 | F-InKind | 6.16 | 2025-06-04 |
| de los Pinos Elisabet | director, officer: See Remarks | 2025-06-02 | M-Exempt | 5.07 | 2025-06-04 |
| Johnson David Michael | director | 2025-05-16 | P-Purchase | 4.9 | 2025-05-20 |
| Johnson David Michael | director | 2025-05-16 | P-Purchase | 4.9 | 2025-05-20 |
| Gibney Anthony S | officer: See Remarks | 2025-05-16 | P-Purchase | 4.9 | 2025-05-20 |
| Gibney Anthony S | officer: See Remarks | 2025-05-16 | S-Sale | 5.15 | 2025-05-20 |
| Gibney Anthony S | officer: See Remarks | 2025-05-16 | P-Purchase | 4.9 | 2025-05-20 |
| Gibney Anthony S | officer: See Remarks | 2025-05-13 | 0 | 2025-05-16 | |
| Gibney Anthony S | officer: See Remarks | 2025-05-13 | 7.21 | 2025-05-16 | |
| Elazzouzi Amy | officer: Senior Vice President, Finance | 2025-04-16 | S-Sale | 5.49 | 2025-04-16 |
| Kilroy Conor | officer: See Remarks | 2025-04-16 | S-Sale | 5.49 | 2025-04-16 |
| Bitetti Teresa Marie | director | 2025-03-31 | A-Award | 5.86 | 2025-04-02 |
| Bitetti Teresa Marie | director | 2025-03-31 | A-Award | 0 | 2025-04-02 |
| Bitetti Teresa Marie | 2025-03-31 | 0 | 2025-04-02 | ||
| Plavsic Mark | officer: Chief Technology Officer | 2025-02-18 | S-Sale | 7.75 | 2025-02-18 |
| Elazzouzi Amy | officer: Senior Vice President, Finance | 2025-02-18 | S-Sale | 7.75 | 2025-02-18 |
| Hopkins Janet Jill | officer: Chief Medical Officer | 2025-02-18 | S-Sale | 7.75 | 2025-02-18 |
| de los Pinos Elisabet | director, officer: See Remarks | 2025-02-18 | S-Sale | 7.7541 | 2025-02-18 |
| de los Pinos Elisabet | director, officer: See Remarks | 2025-02-03 | A-Award | 0 | 2025-02-04 |
| de los Pinos Elisabet | director, officer: See Remarks | 2025-02-03 | A-Award | 7.68 | 2025-02-04 |
| Plavsic Mark | officer: Chief Technology Officer | 2025-02-03 | A-Award | 0 | 2025-02-04 |
| Plavsic Mark | officer: Chief Technology Officer | 2025-02-03 | A-Award | 7.68 | 2025-02-04 |
| Hopkins Janet Jill | officer: Chief Medical Officer | 2025-02-03 | A-Award | 0 | 2025-02-04 |
| Hopkins Janet Jill | officer: Chief Medical Officer | 2025-02-03 | A-Award | 7.68 | 2025-02-04 |
| Kilroy Conor | officer: See Remarks | 2025-02-03 | A-Award | 0 | 2025-02-04 |
| Kilroy Conor | officer: See Remarks | 2025-02-03 | A-Award | 7.68 | 2025-02-04 |
| Elazzouzi Amy | officer: Senior Vice President, Finance | 2025-02-03 | A-Award | 0 | 2025-02-04 |
| Elazzouzi Amy | officer: Senior Vice President, Finance | 2025-02-03 | A-Award | 7.68 | 2025-02-04 |
| de los Pinos Elisabet | director, officer: See Remarks | 2025-01-21 | S-Sale | 7.6704 | 2025-01-21 |
| Elazzouzi Amy | officer: Vice President, Finance | 2025-01-21 | S-Sale | 7.6715 | 2025-01-21 |
| Hopkins Janet Jill | officer: Chief Medical Officer | 2024-11-18 | S-Sale | 9.3608 | 2024-11-18 |
| de los Pinos Elisabet | director, officer: See Remarks | 2024-10-29 | S-Sale | 10.7378 | 2024-10-29 |
| Elazzouzi Amy | officer: Vice President, Finance | 2024-10-29 | S-Sale | 10.7385 | 2024-10-29 |
| Elazzouzi Amy | officer: Vice President, Finance | 2024-10-25 | 0 | 2024-10-29 | |
| Elazzouzi Amy | officer: Vice President, Finance | 2024-10-25 | 5.07 | 2024-10-29 |